The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job losses
Announcement Date
17 December 2004
Employment effect (start)
Foreseen end date
Description
Drugs giant GlaxoSmithKline has announced it is seeking to cut 100 jobs at its Cumbrian plant. Staff at the antibiotics factory in Ulverston have been told the company is offering voluntary redundancy to 100 staff at the site. The job losses are in addition to 400 cuts announced in September 2002, which were carried out over two years.
Sources
17 December 2004: BBC News
Citation
Eurofound (2004), Glaxo Smith Kline, Internal restructuring in United Kingdom, factsheet number 60921, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/60921.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
